Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Reducose® on Symptoms of Perimenopause and Glycemic Response: a Randomized Controlled Trial

NCT07333885 is registered in ClinicalTrials.gov with Phynova Group Ltd as lead sponsor.

NCT NCT07333885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07333885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Reducose® on Symptoms of Perimenopause and Glycemic Response: a Randomized Controlled Trial
Lead sponsor
Phynova Group Ltd
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2025
Completion date
August 11, 2026
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glycemic response, menopause symptoms